These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24843582)

  • 1. Efficacy and safety of ginsam, a vinegar extract from Panax ginseng, in type 2 diabetic patients: Results of a double-blind, placebo-controlled study.
    Yoon JW; Kang SM; Vassy JL; Shin H; Lee YH; Ahn HY; Choi SH; Park KS; Jang HC; Lim S
    J Diabetes Investig; 2012 Jun; 3(3):309-17. PubMed ID: 24843582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model.
    Lim S; Yoon JW; Choi SH; Cho BJ; Kim JT; Chang HS; Park HS; Park KS; Lee HK; Kim YB; Jang HC
    Metabolism; 2009 Jan; 58(1):8-15. PubMed ID: 19059525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy.
    White JL; Buchanan P; Li J; Frederich R
    BMC Endocr Disord; 2014 Feb; 14():17. PubMed ID: 24565221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over clinical trial.
    Vuksan V; Xu ZZ; Jovanovski E; Jenkins AL; Beljan-Zdravkovic U; Sievenpiper JL; Mark Stavro P; Zurbau A; Duvnjak L; Li MZC
    Eur J Nutr; 2019 Apr; 58(3):1237-1245. PubMed ID: 29478187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of α-Cyclodextrin on Cholesterol Control and Hydrolyzed Ginseng Extract on Glycemic Control in People With Prediabetes: A Randomized Clinical Trial.
    Bessell E; Fuller NR; Markovic TP; Lau NS; Burk J; Hendy C; Picone T; Li A; Caterson ID
    JAMA Netw Open; 2020 Nov; 3(11):e2023491. PubMed ID: 33201232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of
    Choi HS; Kim S; Kim MJ; Kim MS; Kim J; Park CW; Seo D; Shin SS; Oh SW
    J Ginseng Res; 2018 Jan; 42(1):90-97. PubMed ID: 29348727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.
    Frías JP; Guja C; Hardy E; Ahmed A; Dong F; Öhman P; Jabbour SA
    Lancet Diabetes Endocrinol; 2016 Dec; 4(12):1004-1016. PubMed ID: 27651331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.
    Oh MR; Park SH; Kim SY; Back HI; Kim MG; Jeon JY; Ha KC; Na WT; Cha YS; Park BH; Park TS; Chae SW
    BMC Complement Altern Med; 2014 Jul; 14():237. PubMed ID: 25015735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension.
    Mucalo I; Jovanovski E; Rahelić D; Božikov V; Romić Z; Vuksan V
    J Ethnopharmacol; 2013 Oct; 150(1):148-53. PubMed ID: 23973636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
    Luis Bautista J; Bugos C; Dirnberger G; Atherton T
    Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
    Ahrén B; Masmiquel L; Kumar H; Sargin M; Karsbøl JD; Jacobsen SH; Chow F
    Lancet Diabetes Endocrinol; 2017 May; 5(5):341-354. PubMed ID: 28385659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.
    Mathieu C; Ranetti AE; Li D; Ekholm E; Cook W; Hirshberg B; Chen H; Hansen L; Iqbal N
    Diabetes Care; 2015 Nov; 38(11):2009-17. PubMed ID: 26246458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial.
    Terauchi Y; Tamura M; Senda M; Gunji R; Kaku K
    Diabetes Obes Metab; 2017 Oct; 19(10):1397-1407. PubMed ID: 28371205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus.
    Kawamori R; Kaku K; Hanafusa T; Kashiwabara D; Kageyama S; Hotta N
    J Diabetes Investig; 2012 Jun; 3(3):302-8. PubMed ID: 24843581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 8-wk, randomized, double-blind, placebo-controlled clinical trial for the antidiabetic effects of hydrolyzed ginseng extract.
    Park SH; Oh MR; Choi EK; Kim MG; Ha KC; Lee SK; Kim YG; Park BH; Kim DS; Chae SW
    J Ginseng Res; 2014 Oct; 38(4):239-43. PubMed ID: 25379002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial.
    Mosenzon O; Blicher TM; Rosenlund S; Eriksson JW; Heller S; Hels OH; Pratley R; Sathyapalan T; Desouza C;
    Lancet Diabetes Endocrinol; 2019 Jul; 7(7):515-527. PubMed ID: 31189517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifty-two-week, randomized, multicenter trial to compare the safety and efficacy of the novel glucagon-like peptide-1 analog liraglutide vs glibenclamide in patients with type 2 diabetes.
    Kaku K; Rasmussen MF; Nishida T; Seino Y
    J Diabetes Investig; 2011 Nov; 2(6):441-7. PubMed ID: 24843528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus.
    Kashiwagi A; Kazuta K; Yoshida S; Nagase I
    J Diabetes Investig; 2014 Jul; 5(4):382-91. PubMed ID: 25411597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.